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T cells responsible for allograft immunity are known to perform at least two
functions: primary recognition of products of the major histocompatibility
complex (MHC)' and an effector function which is completed with destruction of
grafted tissue . Both functions have expression in vitro, the former in the
proliferative response of normal lymphocytes in mixed culture (1), the latter in
the cytotoxic effect (CE) of immune lymphocytes upon allogeneic target cells
(TC) (2). TC destruction in the latter case is also preceded by recognition of an
immunizing complex by lymphocyte receptors, as shown bythe selective removal
of killer lymphocytes from the population as a result oftheirspecific adherence to
the corresponding TC (3).
Recognizing T (RT) cells and effector T (ET) cells were shown to react to
products of different MHC regions: RT recognize the products of the mixed
lymphocyte culture (MLC) locus which is mapped mainly in the immune
response (Ir) region of MHC (4), whereas ET cells react to H-2K and H-2D
products, the induction ofET cells beingpreceded by MLC reaction (5) which, in
its turn, requires differences in MLC locus (6). In case of differences in MLC
locus but identity of H-2 loci in mice (6) or HL-A loci in human (7-9), CE does
not develop, even though MLC reaction is taking its normal course .
These findings were interpreted to mean that the reaction to transplantation
antigens involves cooperation of two T-cell populations, each recognizing
products of different MHC regions (10, 11). This model, however, is not in
agreement with observations made on mutant strains of mice. A single
difference in H-2D locus between the original B10.D2 strain and B10.504 mutant,
* This work was partially supported by a grant from the World Health Organization.
Abbreviations used in this paper: AI, absorption index ; CE, cytotoxic effect; CML, cell-mediated
lympholysis; ET cells, effector T cells; 199 LB, medium 199 with lactalbumin and bovine serum; LD,
lymphocyte defined ; MHC, major histocompatibility complex; MLC, mixed lymphocyte culture;
MST, medium survival time; Rim, release with immune lymphocytes; Pt..., maximum release; Rorm,
release with normal lymphocytes; Rap, spontaneous release ; RT cells, recognizing T cells; SD,
serologically defined; TC, target cells.
THE JOURNAL OF EXPERIMENTAL MEDICINE - VOLUME 141, 197512
￿
PRIVATE H-2 AS TARGETS FOR CELL-MEDIATED LYMPHOLYSIS
due apparently to a point mutation of this locus (12, 13), proved to be sufficient
for induction ofboth ET cells (14) and RT cells (13). Serologically undetectable
differences in the "K-end" of MHC between C57BL/6 strain and H(zl) mutant
appearedto be responsible for both MLC reaction and cell-mediated lympholysis
(CML), as well as for skin graft rejection (15, 16). Genes governing MLC reaction
were suggested to be distributed through MHC and not restricted to Ir (17, 18).
Thus, the arrangement of"MLC locus genetic determinants, whose products are
recognized by RT cells, remains obscure; at the same time, most data favor a
decisive role of H-2K and H-2D loci products in both induction (6) and
realization of CML (19). This does not mean, however, that the serologically
defined (SD) entities of these loci are themselves recognizable by ET cell
receptors.
Each of H-2 loci (K or D) is known to govern only a single private H-2
specificity which is strictly peculiar to the particular allele ofthe given H-2 locus .
Conversely, public H-2 specificities may be coded by either H-2 locus and are
detectable in differentH-2 haplotypes (18, 20). Although both private and public
H-2 specificities are capable of inducing antibody formation, their role in
cell-mediated immunity may prove to be nonequivalent. The present study was
designed to test whether private or public H-2 specificities, or both of them,
constitute the recognizable unit for ET cell receptors during absorption of
cytotoxic lymphocytes on TC and subsequent CE in vitro and also during
accelerated skin graft rejection in vivo.
It has been demonstrated that ET do not recognize public H-2 specificities but
react selectively either to private H-2 specificities or to serologically silent
products of H-2K and H-2D loci closely linked to private H-2 specificities.
Preliminary results of the present study have been published elsewhere (21).
Materials and Methods
Animals.
￿
Mice of congeneic strains C57BL/10 ScSn (H-2°) (abbreviated B10) and C57BL/10-H-
2° (abbreviated B10.D2) were bred at the Gamaleya Institute, Moscow. Congeneic strains of mice
with recombinant H-2 haplotypes B10. A(H-2°), B10.D2 (R107) abbreviated R107 (H-2`-ES), B10.D2
(R101) abbreviated R101 (H-28-18), B10.A(2R) abbreviated 211 (H-2"-"e), B10.A(5R) abbreviated
5R(H-2-zs8), as well as B10.M(H-2f) and DBA/1 (H-2Q) were bred at the Laboratory of Tissue
Compatibility Genetics of the General Genetics Institute, USSR Academy of Sciences. H-2haplotype
of the above strains are presented in Table I according to Demant (18) and Vedernikov andEgorov
(22). Mice aged 10-16 wk were used in the experiments.
Tumor.
￿
MX11 sarcoma in 1310 mice induced with methylcholanthrene, converted into theascite
form and maintained by every week passages .
Immunization.
￿
B10.D2 mice were immunized with a single dose of twice washed sarcoma cells
administered at five subcutaneous sites and intraperitoneally, 40 to 50 x 10' viable cells per mouse
(23).
Experiments on Cytotoxici Effect of Immune Lymphocytes. The techniques for preparing
immune lymphocyte suspensions and target cell cultures, those for assessment of cell viability and
cytotoxic activity, as well as quantitation ofthe latter, have been described in detail previously (3, 14,
23). In the present study they were slightly modified, as follows.
Regional lymph nodes were taken 8 days after immunization. Dissociated cell suspensions were
prepared by forcing the lymphoid tissue through a 100 mesh stainless steel seave with subsequent
removal of cell clumps by sedimentation at unit gravity. Peritoneal macrophages, used as target cells,B. D. BRONDZ, I. K. EGOROV, AND G. I. DRIZLIKH
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were harvested in 48-72 h after intraperitoneal injection of an irritant (solution of 3% peptone and
0.15% glycogen in saline), counted in a hemocytometer and seeded into Leighton tubes in portions
containing 2.5 x 106 cells per 1 ml of 199 medium supplemented with 20% bovine serum, 10%
lactalbumin hydrolysate solution and antibiotics (199 BL Medium) . Target cells were grown for 2
days as nonconfluent uniform monolayers in the atmosphere of 5% CO, or in the presence of0.005 M
Hepes. Immune and normal lymph node cells from mice of the same strain were washed twice with
Hanks' solution, resuspended in 199 medium containing 5% fetal calf serum (FCS) and 0.005 M
Hepes, and counted using amixture of0.1%solutions of aqueous eosine andtrypan blue. 2 x 10°, 4 x
108 or 8 x 108 lymphocytes were added in 1 ml vol to previously washed Leighton cultures of target
cells to be investigated. Four replicate cultures were used for each lymphocyte dose. After incubation
overnight, the culture medium with free lymphocytes was replaced by 199 medium containing 5%
bovine serum; the next day, no less than 300 surviving macrophages were counted in each tube, using
magnification x200 and eosine-trypan blue mixture, andthe mean numbers oftarget cells per field of
vision were multiplied by 108 (the number of fields of vision perflat tube surface).
CE was calculated as (a - b) 100/a, where a and b represent mean numbersof surviving TC follow-
ing incubation with normal and immune lymphocytes, respectively. Differences in results were
assessed for significance by Student's t test .
The Cytotoxic Assay Based on "Cr Release.
￿
The cytotoxic assay based on "Cr release according
to Hayry et al. (24) wasused in some early experiments of this study with a number of modifications.
48-h Leighton cultures of TC were washed and incubated for 2 h with 1 ml 199 medium containing
10% FCS ans 100,Ci/ml "Cr (spec act 50 mCi/mg). Then followed four washings with 3-ml vol of 199
BL medium, and normal and immune lymphocytes were added to macrophages as above. To assess
spontaneous release (R,,) of the label, TC were incubated in 199 medium with 5% FCS without the
addition of lymphocytes. Maximum release (Rm) was assessed following treatment of TC with 2%
sodium dodecylsulphate (SDS) diluted in 0.05 M borate with 0.002 M EDTA. After incubation for 20
h at 37°C, the tubes were gently shaken, the culture medium harvested, and each culture washed
twice with 0.5 ml of 199 BL medium . Radioactivity in pooled culture medium and washings was
measured in a Nuclear Chicago gamma counter (Nuclear-Chicago Corp., Des Plaines, Ill.) . The
culture fluid was not centrifuged, since preliminary experiments showed that some particular
component of the label released from destroyed macrophages can thus escape determination. Under
the above conditions, Rm.. amounted to 1.5 x 106-4 x 106 CPM, R., constituted 28 to 33% of Rmax,
while R,o_ (release of the label following incubation with normal lymphocytes) exceeded R., by 10 to
20% making up 35 to 45% with respect to Rme,. We succeeded in decreasing the magnitude of Rorm to
the level of R,P by cultivating TC on glass surfaces covered by poly-L-lysine (25) . Still lower values of
R._ were obtained if normal lymphocytes were absorbed by syngeneic target cells, as described
below.
In later experiments of this study the technique of CE determination using "Cr release was
modified as follows (26). After harvesting into a siliconized tube from the peritoneal cavity,
macrophages were centrifuged for 5min at 900 rpm, suspended in 199 medium with 10%FCS and75
,uCi/ml "Cr, andincubated at the concentration of 1 x 10°-2 x 10° cell/ml for 1 hr at 37°C in awater
bath with occasional agitation. After the incubation, cells were washed three times with 199 BL,
counted again, and delivered to Leighton tubes previously covered with poly-L-lysine by 4 x 106 cells
in 1 ml of 199 BL medium containing 0.005 M Hepes. After 2days of incubation at 37°C, the cultures
were washed three times with 199 BL, and addition of lymphocytes and subsequent operations were
made as described above. With this procedure, R,,,. did not exceed 15-20% of Rm_ The cytotoxic
effect of immune lymphocytes was calculated as specific release = (R,m - R_m)/Rme, - RnDrm) x
100.
Absorption of Immune Lymphocytes. Absorption was carried out using previously described
methods (3, 19) with some modifications. Almost confluent monolayers were prepared by seeding 5 x
108 or 15 x 108 peritoneal macrophages per 60-mm Carrel flask or 250-ml plastic bottle (no. 3024,
Falcon Plastics, Div of BioQuest, Oxnard, Calif.), respectively, 2 days before experiment. After
washing out of nonadherent cells, the immune lymphocytes suspended in 199 medium with 10%
bovine serum were added to the Carrel or plastic bottle cultures (30-50 x 10 8 cells in 2.5 ml vol in the
former case, and 90-150 x 108 cells in 7-ml vol, in the latter) .
After incubation for 3 h at 30°C, the vessels were rocked on a shaker (New Brunswick Scientific Co.14
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Inc., NewBrunswick, N. J.) at 100 rpm for 5 min, andthe nonadherent lymphocytes were harvested
using additional rinsing of the vessels with a small portion of the medium and manual shaking. The
above procedure of absorption wasrepeated on anewmonolayer of macrophages andall nonadherent
lymphocytes were pooled, spun down, resuspended in 199 medium containing 5% FCS, and counted.
Absorption of normal lymphocytes on syngeneic B10.D2 target cells was performed in the same way.
Equal doses of viable nonadherent and untreated immune lymphocytes were then compared in
parallel for cytotoxic activity. The absorption index (AI) was calculated as (a - b) 100/a, where a
and brepresent the cytotoxic effects ofintact and nonadherent immune lymphocytes, respectively .
Skin Grafting.
￿
Tail skin grafts from four donors to theback ofonerecipient animal were made by
a modification (27) of the Billingham and Medawar method (28). Plaster bandages were removed 6
days later, and grafts were scored as rejected when no viable epithelium remained on inspection of the
grafts.
Experimental Design. As indicated in Table I, BIO.D2 anti-1310 lymphocytes are potentially
directed against seven H-2 specificities of which two are private, coded by H-2K° (specificity 33) and
H-2D° (specificity 2), and five public ones (H-2.5, 39, 53, 54, and 56) . These lymphocytes were
brought in contact with different TC possessing the following specificities from the enumerated
above: H-2.5 (1310 .A strain), H-2.39 and 53 (B10.M strain), H-2.54 and 56 (DBA/1 strain), H-2.2
(R101 strain), H-2.5, 33, and39 (possibly also H-2.53, 54, and56) (R107 and 511 strains), H-2.2 and 5
(2R strain), as well as with a mixture of R107 and R101 target cells, possessing both private
specificities, H-2.2 and H-2.33.
Reactions with TC of the donor (1310) and recipient (B10.D2) were used as positive andnegative
controls, respectively. In in vivo experiments, B10.D2 mice were immunized by a single intraperito-
neal injection of 5 x 10° B10spleen cells and used, 7 days later, as recipients for skin grafting from
four mouse strains: 1310, B10.A, 13107, and R101.
Results
With all the doses used (8, 4, and 2 millions), B10.D2 anti-1310 lymph node cells
destroyed TC ofthe donor (1310) but didnot affect those of the recipient (B10M)
or third-party strains B10.A, MOM, or DBA/1 (Table I). The degree of CE on
1310 TC was proportional to the lymphocyte dose. Absence of the reaction with
third-party TC indicates that public specificities H-2.5; H-2.39, 53; H-2.54, 56
are not involved in the reaction, since, with the above three strains, the
lymphocytes could theoretically respond to only those public specificities. These
results are in agreement with our previous observations (3).
However, partial CE was produced in the above experiments by the same
lymphocytes on TC from recombinant strains R107, R101, and 2R. If, based on
Table I data, CE on B10 TC is assumed to be 100%, the corresponding effects on
R107 and R101 TC amount to about 75% and 25%, respectively, and are, thus, in
the proportion of 3:1. The results were similar whether the cytotoxicity tests
employed viable cell count (Exp. 1-4) or "Cr release from destroyed TC (Exp.
5-7). So far as H-2.5, 39, 53, 54, and 56 specificities do not seem to participate in
the reaction, it should be assumed that 75% of the activity of MOM anti-1310
lymphocytes is directed against the private specificity Hr2.33 and 25% against
the private specificity H-2.2. This assumption is supported by the observation
that the effect of the same lymphocytes on a 3:1 mixture of R107 and R101 TC
approached 100% (or even exceeded that level) . In some experiments, TC of 2R
strain were destroyed somewhat more readily than those ofR101, due, mainly, to
a higher activity of the lowest lymphocyte dose (Table I).
The lack of CE in the immune lymphocyte reaction with third-party TC, whichB. D. BRONDZ, I . K. EGOROV, AND G. I. DRIZLIKH 15
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share only public H-2 specificities with the donor could be connected with
inability of the lymphocytes to attach to these TC, because their antigen-binding
receptors do not recognize public H-2 specificities. To test this possibility,
1310.1)2 anti-1310 lymphocytes were subjected to absorption by macrophages of
different origin with subsequent testing of the nonadherent lymphocytes for CE
on B10 TC.
It follows from Table 11, that in two independent experiments (employing
TABLE II
Absorption ofAnti-B10BIOM Lymphocytes by Target CellsPossessing Private or Public
Specificities of H-2K and H-21) Loci
Source of
No. oflympho-
cytes (x 10e)
￿
Cytotoxic
H-2 seci-
￿
effect on Absorp-
￿
Relative absorbing
* 5 x 10° peritoneal cellswere seeded per Carrel flask 8 cm in diameter and cultivated for 2 days to
obtain an almost confluent monolayer.
$ H-2 specificities ofabsorbingcells potentially capableof reacting with lymphocytes (see TableI).
§ Two times for 3 h at 30°C.
11 Nonadherent lymphocytes were harvested, washed one time, counted, and tested on B10 target
cells.
4Significance of the difference between the cytotoxiceffectsoflymphocytes absorbed with the given
stated specific target and with B10.D2 target incapable of specific absorption.
target cells
forabsorption* ficities$ For
absorp-
tion§
For
testil
B10target
cells
tion
index
activity of
target cells
None 8 83.8
4 64.0
1310 2; 33; 5; 39; 50 8 22.6 73.0 100 (P~ < 0.001)
53 ; 54; 56 30 4 6.5 90.0 100 (P4 < 0.001)
B10.D2 None 50 8 75.5 9.9 13.6
30 -4 64.2 0 0
B10.A 5 50 S 77.0 8.1 10.9 (PT > 0.1)
30 4 61.8 3.4 3.8 (P4 > 0.1)
B10.M 39;53 30 4 64.8 0 0 (PT > 0.1)
R107 33;5;39;53; 50 8 56.4 32.7 44.8 (P5 < 0.01)
54; 56 30 4 30.2 52.9 58.8 (PT < 0.001)
R101 2 50 8 84.8 0 0 (P~ > 0.05)
30 4 40.2 37.2 41.5 (PT < 0.01)
R107 + R101 2 + 33; 5; 39; 50 8 37.3 55.5 76.2 (Pt < 0.001)
3:1 53; 54; 56 30 4 -3.0 100 100 (PT < 0.001)
211 2;5 50 8 84.1 0 0 (P~ > 0.05)
30 4 40.4 36.9 41.0 (PQ < 0.01)B. D. BRONDZ, I . K. EGOROV, AND G. 1. DRIZLIKH
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different lymphocyte doses) CE ofthe lymphocytes, reaching 83.8% and 64%, was
inhibited by 73% and 90%, respectively, following absorption with B10 macro-
phages, but not reduced significantly after absorption with B10.D2 TC. Macro-
phages ofB10.A and B10.M strains, also, either failed to affect the activity ofthe
nonadherent lymphocytes or reduced it nonspecifically by no more than 8.1%
(differences in the absorbing activities between MOM, B10.A, and B10.M are
not significant: P > 0.1). Similarresultswereobtained followingabsorption with
DBA/1 TC (not shown in Table 11). By contrast, absorption of the lymphocytes
with R107, R101, and 2R TC reduced CE by 52%, 37.2% and 36.9%, respectively
(P < 0.01 in all the cases), which constitutes 60%, 40%, and 40% ofthe Al ofB10
TC. The latter result, shown in detail in Fig. 1, was obtained using comparatively
NO obs.
obs 8102
obs. 810
obs.BIQA
abs. 810 .M
abs. RIO?
obs. RIM
obs. 2R
abs.
R107+Riot3
10 20 30 40 SO 60 70
per cent
FIG. 1 . Cytotoxic activity of anti-1310 1310.D2 lymph node cells absorbed by target cells
possessing private or public specificities of H-2K° or H-2D° alleles. 3 x 10' lymphocytes were
incubated two times for 3 h at 30°C on a monolayer of macrophages seeded two days
previously in the amount of 5 x 10° per Carrel flask. Strains of mice used as a source of
absorbing macrophages are shown on the ordinate. The nonadherent lymphocytes were
harvested, washed one time, counted, and the cytotoxic effect of 4 x 10, lymphocytes was
tested on B10 target cells. Each column represents the arithmetic mean (fSD) of cytotoxic
effects found in four replicate tubes.
low doses of the lymphocytes for absorption (30 x 108 cells per Carrel flask) and
for CE assay (4 x 108 cells per tube) which insures practically complete
exhaustion of CE towards 1310 TC.
Absorption with a mixture of R107 and R101 TC in this case resulted in
complete inhibition ofthe lymphocyte activity. However, ifthe dose of absorbed
and tested lymphocytes was in excess, not providing for complete exhaustion of
CE towards B10 TC, the absorbing activity ofR107 macrophages became lower,
that of R101 and 2R strains was not evident at all, while themixture ofR107 and
R101 TC resulted in incomplete reduction of the lymphocyte activity (Exp. 1,
Table 11).
These findings permitted a suggestion that the receptors of effector lympho-18
￿
PRIVATE H-2 AS TARGETS FOR CELL-MEDIATED LYMPHOLYSIS
cytes, determining their specific attachment to TC, do not recognize public H-2
specificities and react only with private ones, there being two lymphocyte
populations each recognizing only one of the private specificities, either H-2K or
H-2D . Immunization with both H-2.33 (K°) and H-2.2 (D°) specificities could
induce the two respective lymphocyte populations in unequal proportion : their
greater part could be directed against the private specificity H-2K, while the
smaller part against the private specificity H-2D. If the suggestion is correct,
selective removal from the immune lymphocyte suspension of cells directed
towards only one of the private specificities should not affect CE upon
macrophages possessing the alternate private specificity .
It follows from Table III that experimental findings agreed with behavior
expected from the above suggestion. Cytotoxicity of B10.D2 anti-1310 lympho-
cytes towards R107 or 5R TC, ranging in different experiments from 36 .8% to
73.1%, was suppressed by 63-100% following absorption with R107 TC but did
not diminish after absorption with R101 and 211 TC . Some insignificant
reduction of CE in a part of experiments is nonspecific, since AI of the same
magnitude are observed following incubation of the immune lymphocytes with
syngeneic B10.D2 macrophages incapable of specific absorption . In the above
experiments CE of the same lymphocytes against R101 and 211 macrophages,
ranging from 17% to 34%, was maintained following absorption with R107 TC
(exp. 1, 2, 4) or with 5R TC (Exp. 3) possessing similar H-2 haplotypes (K°D') .
At the same time, absorption with R101 macrophages removed lymphocytes
cytotoxic for both R101 and 211 TC and, furthermore, absorption with 211
macrophages cancelled CE not only against 2R but against R101 TC, as well . In
both cases, cross-absorption amounted to 79-100% (Table III) . Just like in the
previous series of experiments, the results did not depend on the method of
testing whether by TC count or specific "Cr release.
Thus, absorption of d anti-b lymphocytes with macrophages, possessing H-
2Db private specificity, H-2.2, in combination with the H-2K private specificity
of non-H-2° origin (not H-2.33) cancels CE of the lymphocytes upon any TC pos-
sessing H-2.2 specificity but does not affect CE upon TC bearing the other private
specificity H-2.33. At the same time, sharing of public specificities by absorbing
macrophages with H-2° does not affect CE of the lymphocytes.
The ability of ET lymphocytes to react only with private H-2 specificities is
supported by results of in vivo experiments on skin transplantation to B10.D2
mice previously immunized with a small dose of B10 mouse spleen. Following
such immunization not only donor (1310) grafts were rejected at an accelerated
fashion, but also those of R107 and R101 recombinant strains, bearing single
private specificities H-2.33 (K°) and H-2.2 (D°), respectively . On the contrary,
there was no significant acceleration in rejection of B10.A skin graft, possessing
only public H-2.5 specificity out of donor H-2 specifities foreign to the host
(Table IV).
Discussion
The main two findings of the present work are the following: (a) ET lymphocytes
do not recognize public H-2 specificities . (b) ET lymphocytes recognize private
H-2 specificities or structures closely related to them.B. D. BRONDZ, I. K. EGOROV, AND G. I. DRIZLIKH
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TABLE III
Cross-Absorption of Anti-B10 BIO.D2 Lymphocytes with Target Cells Possessing
H-2.33(K°) or H-2.2(D°) Private Specificities*
Source
￿
Source andH-2private specificity of absorbingtarget cells
`8 x 10° lymphocytes were incubated for 3 h at 30°C successively in two 250-ml plastic bottles,
containing monolayer of peritoneal macrophages; the nonadherent cells were harvested, one time
washed, counted, and the cytotoxic effect of 8 x 10° lymphocytes was tested.
$ Cytotoxic effect was assessed by target cell count in Exp. 1 or by "Cr release in Exp. 2, 3, 4.
§ R107 target cells are used in Exp. 1, 2 and 4, 511 target cells are used in Exp. 3. NT, nottested.
11 Difference betweenthe cytotoxiceffectsoflymphocytes absorbed with thestated specific target and
with 131O.D2 target (or nonabsorbed lymphocytes) is highly significant (P < 0.01). In other cases
the same difference is not significant (P > 0.05) .
T In parenthesis: absorption index.
Previously, we obtained evidence that ET lymphocytes were incapable either
of specific absorption on third-party TC or of destroying such cells, if the latter
possessed only part of the immunizing H-2 antigenic complex (3, 14). Moreover,
no CE was produced on third-party TC even after mixing three lymphocyte
populations, directed towards different H-2 specificities, or after mixing TC of
different origin, each possessing only some specificities of the immunizing H-2
complex (14, 19). H-2K and H-2D specific complexes, localized on the same
immunizing cell of A strain, were recognized by receptors of two different
populations of C57BL anti-A lymphocytes, which was proved by selective
removal of each of the populations by absorption of the lymphocytes with
corresponding TC (19). These findings have been corroborated (29-31) and an
explanation has been proposed (32) that, in the course of theimmune response to
H-2K or H-2D antigenic membrane complexes, the polyspecific precursors of
ET cells give rise to the progeny-bearing receptors with complex polyvalent
structure which is a mirror reflection of the reciprocal arrangement of H-2K or
H-2D antigenic determinants on the surface of the immunizing cell.
In most of the experiments mentioned, third-party TC shared with the donor
of target
cellsfor
test
Exp.
no.$ None 8107 or 5R§
H-2.33
R101
H-2.2
Cytotoxiceffect
211
H-2.2
(%)
1310 .D2
None
R107 or 1 60.0 -4.611 (>100)4 60.5 (0)4 60.3 (0)~ NT
5R§ 2 55.6 -11.011 (>100) 50.9(8.5) 48.7(12.3) 50.3(9.5)T
3 73.1 26.811 (63.3) 60.0 (17.9) 61.2 (16.3) 60.1 (17.8)
4 36.8 2.711(92.7) 30.3 (17.6) 19.2 (47.8) 27.3 (25.8)
R101 1 25.8 30.0(0) -2.211 (>100) -1.611 (>100) NT
2 22.5 25.0(0) NT 3.711(83.6) NT
3 24.5 14.2 (42.0) -2.511 (> 100) -9.511 (> 100) 25.0(0)
4 19.0 18.4 (3.2) 011 (100) 1.111 (94.2) 16.3 (14.2)
2R 1 34.0 29.6(12.4) -7.411 (>100) -1.611 (>100) NT
2 31.7 23.8 (24.9) 6.611 (79.2) NT NT
4 17.0 7.2(57.7) 3.111 (81.8) -1.511(>100) 8.7(48.8)20
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TABLE IV
Rejection of Skin Grafts of Mice with Different Genotypes by
B10.D2 Recipients Preirnmunized with B10 Spleen Cells*
* 5 x 10° spleen cells were injected intraperitoneally 7 days before skin
grafting.
public H-2 specificities only. In this connection, an alternative explanation ofthe
results is possible, namely : that receptors of ET lymphocytes are not capable of
recognizing public H-2 specificities at all and selectively react to onlyprivateH-2
specificities. In such a case, partial destruction of strain A TC by B10
anti-B10.D2 and C3H anti-B10.D2 lymphocytes (3, 14) could be due to the fact
that the donor (B10.D2) TC and those of the third-party (A) strain possess a
common private specificity H-2.4 (Dd) which is lacking in the recipient.
Detailed investigation of this issue in the present study, carried out with
recombinant strains of mice, has supported the above suggestion. MOM
anti-B10 lymphocytes, which are potentially directed against seven H-2
specificities-five public ones (H-2.5, 39, 53, 54, 56) and two private ones (H-2.2
and H-2.33)-did not react with macrophages of B10.A, MOM, and DBA/1
strains possessing only public specificities H-2.5, H-2.39, 53 and H-254, 56
respectively, but reacted with 11101 and 11107 TC with their respective private
specificities H-2.2 (D°) and H-2.33 (K°). Occurrence or absence of the reaction
was expressed not only in direct TC destruction but also in the ability of TC to
absorb the appropriate ET lymphocytes and to remove them from the suspen-
sion. It is evident that receptors of ET lymphocytes react only with private H-2
specificities.
Data ofthe present work show that immunization with both private specifici-
ties (H-2.2 and H-2.33) carried by the same immunizing cell results in induction
of the two respective ET populations in unequal proportion: a greaterpart of the
lymphocytes (60 to 80%) is directed towards H-2K private specificity, while the
smaller one towards H-2D private specificity. That these two ET populations do
not overlap is demonstrated by experiments on cross-absorption of the lympho-
cytes on TC ofone of the recombinant strains (11107, 11101, 211, and 511) with sub-
Graft
donor
Normal or
immune re-
cipients
No. of
recipients
MST t SE
(days)
P
B10 Normal 9 9.7 f0.33
Immune 10 6.0 t0
<0.001
B10.A Normal 8 9.6 f 0.42
Immune 8 8.5 t 0.5 >0.05
11107 Normal 8 9.3 t 0.6
Immune 10 6.7 f0.3
<0.001
11101 Normal 8 12.4 f 0.56
Immune 10 7.9 t 0.66
<0.001B. D. BRONDZ, I . K. EGOROV, AND G. I. DRIZLIKH
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sequent testing of nonadherent lymphocytes upon each of the recombinant
strains. Following complete removal ofET cells, which react with TC ofR107and
5R strains (reaction due to H-2.33 specificity), CE is maintained towards R101
and2R TC (reaction due to H-2.2specificity), and, conversely, removal oflympho-
cytes reactive with H-2.2 specificity does not affect CE against R107 TC, bearing
H-2.33 specificity. In addition, if the lymphocytes are absorbed on the macro-
phages of one ofthe strains bearing H-2.2 specificity (R101 or 2R), this results in
removal of lymphocytes killing not only the particular strain used for absorption
but also the other strain sharing that private specificity. Finally, a mixture of
TC, each bearing oneofthe two immunizing private specificities, absorbs 100% of
immune lymphocytes and is completely destroyed by them.
The ability ofET lymphocytes, immune to H-2K private specificity, to destroy
greater numbers of TC, compared with lymphocytes immune to H-2D private
specificity, is compatible with our previous data obtained in another system of
strains (19) and seems tobe due to more numerous ET cells induced as a result of
incompatibility in H-2K, compared with that in H-2D. A number of other
observations may be connected with this feature: H-2K incompatibility is known
to be a more effective stimulator ofblastogenesis in vitro (33) and in vivo (34), of
humoral lymphotoxin elaboration in MLC (35), of graft-vs.-host reaction (36),
and of plaque-forming cell development to SRBC (37), as well as it results in
shorter survival time of skin allografts (38), than the incompatbility in H-2D.
Greater immunogenicity of H-2K locus products, than that of H-2D locus
products, is, possibly, related to the neighborhood of H-2K locus to Ir-region in
IX linkage group (20). If a product of MLC gene of Ir-region is located on the
cellular membrane close to those of H-2K gene, it could enhance indirectly the
induction and/or proliferation of ET cells. An alternative view that a part ofET
lymphocytes is directed, likeRT lymphocytes, against the very products of MLC
gene, mapped in Ir-region, does not agree with experimental findings (see
introduction).
The ability of ET lymphocytes to react only with private H-2K and H-2D
specificities and not with public H-2 specificities is not merely a laboratory
phenomenon: similar regularities are found in vivo in rejection of skin allograft
under conditions of an overlap in private or public H-2 specificities; it is in the
first case, only, that the graft is rejected at an accelerated fashion in preimmu-
nized animals (Table IV).
This result is in accordance with data obtained by one ofus earlier (39), but at
variance with those reported by Klein and Murphy (40). The discrepancy is,
probably, due to the fact that mice in the latter study were immunized with a
comparatively large antigenic dose, administered as a cell-free extract, and to
assessment of the rejection rate by different techniques. A large antigen dose
could induce an early elaboration of antibodies which act synergically with im-
mune lymphocytes in the second-set rejection either ofa third-party graft (39) or
under the conditions ofreducing lymphocyte activity (41).
The inability ofET lymphocytes to react with public H-2specificities suggests
that there may exist structures recognizable by receptors ofonly B lymphocytes
and not by those of T cells. It has been shown earlierthathaptensdo not activate22
￿
PRIVATE H-2 AS TARGETS FOR CELL-MEDIATED LYMPHOLYSIS
T-helper cells (42) and do not react with effectors of cell-mediated immunity (43,
44). It is established by the present work, based on absorption criterion, that a
large group of natural cellular membrane determinants-public H-2 specificities
-are not recognized by receptors of ET lymphocytes, in spite of the fact that
they are known to be capable of both inducing humoral antibodies and reacting
with them readily.
It is not known what restricts the variety of T-cell receptors, compared with
those of B cells, and what determines the privilege of being recognized by T
cells. However, it is tempting to think that T-cell receptors recognize selectively
some specific class of conformational determinants, whereas B-cell receptors can
react with configurations of any type, including those structures which are
recognized by T-cell receptors.
It is not excluded that a definite steric association of public specificities results
in appearance of a conformational determinant which, in fact, constitutes a
private specificity, in other words, that private specificities are determined by
the primary structure of public specificities . Results of investigations with the
use of mutant H-2 haplotypes are indicative of such a possibility: a mutation in
just one or two of the public H-2 specificities is invariably accompanied by
appearance of a new private H-2 specificity (12) .
Data obtained in this study provide evidence in favour of the contention that
H-2 antigens are natural hapten-carrier complexes (10, 11), public specificites
being the equivalent of hapten in this complex, while the role of carrier
determinants is, possibly, played either by private specificities themselves or
some other serologically silent products of H-2K and H-2D loci, closely linked to
the private specificities (45) . Therefore, the carrier and hapten determinants
could either overlap partially (in the former case) or be sterically spaced (in the
latter case) just like it is observed in some other systems (46-48). It does not
appear possible at present to chose between the two alternatives.
The suggestion about selective recognition of private SD specificities by ET
lymphocyte receptors should be reconciled with the results of reciprocal
immunization between 1310-derived mutants (Hzl, M505) and the original B10
strain, which indicated development of CML in spite of absence of any SD
differences (15, 16, 45). The apparent inconsistency may be explained by a
requirement in accessory gene expression to produce antibody against some
private specificities of B10 background (49) . The latter feature appears to be
unique for H-2° haplotype, since SD differences were invariably observed
between original strains possessing other haplotypes (H-2d or H-2f) and their
respective mutants (12, 45). Thus, failure to reveal SD differences does not
necessarily mean absence of such differences in private specificities.
If, on the other hand, some serologically silent portion of the molecule, coded
by H-2K or H-2D locus, constitutes the target for ET lymphocytes, a question
arises about the relation of this portion to the lymphocyte-defined (LD)
determinants coded by MLC loci which map in Ir (4) and D (13, 50) regions of
MHC.
It can be supposed that these determinants are identical and contribute to the
composition of two different types of molecules coded by MHC. One of theB. D. BRONDZ, 1 . K. EGOROV, AND G. 1. DRIZLIKH
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molecule types, carrying SD H-2 specificities and capable of inhibiting the
cytotoxic activity of ET lymphocytes (51) is a product of two genes, of H-2K or
H-2D, on the one hand, and of MLC gene in the K or D regions, on the other
hand. Therefore, this type of molecule possessed the property of a hapten-carrier
complex. The other type of molecules, coded exclusively by MLC gene, does not
bear SD H-2 specificities and performs only carrier functions. For some reason,
for instance, due to a difference in the determinant density on the cellular
surface, molecules possessing SD H-2 specificities present more adequate targets
for ET cells, but less readily activate RT lymphocytes, whereas molecules devoid
of the serological specificities are more active stimulators of RT lymphocytes but
less suitable targets for ET lymphocytes (52).
It follows from the proposed model that RT and ET cell receptors react with
identical or very similarproducts of MHC locus, as distinct from B-cell receptors
which react with SD H-2K and H-2D specificities. Experiments utilizing the
above models as a working hypothesis are being conducted at present.
Receptors of effector T lymphocytes of congeneic strains of mice do not recognize
public H-2 specificities and react to private H-2 specificities only. This has been
established with the use of three tests: direct cytotoxicity assay of immune
lymphocytes upon target cells, specific absorption of the lymphocytes on the
target cells, and rejection of skin grafts at an accelerated fashion. Immunization
with two private H-2 specificities in the system C57BL/1OScSn , B10.D2
induces formation of two corresponding populations of effector lymphocytes in
unequal proportion: a greater part of them is directed against the private
specificity H-2.33 (K°), while the smaller part is towards H-2.2 (D°) private
specificity. These two populations of effector lymphocytes do not overlap, as
demonstrated by experiments on their cross-absorption on B10.D2 (11107),
B10.D2 (11101), B10.A(2R), and B10.A(5R) target cells, as well as on mixtures of
11107 and 11101 targets. Following removal of lymphocytes reacting with one of
the private H-2 specificities, lymphocytes specific to the other specificity are
fully maintained. A mixture of target cells, each bearing one of the two
immunizing private specificities, absorbs 100% of the immune lymphocytes and
is totally destroyed by them.
It is suggested that H-2 antigens are natural complexes of hapten-carrier type,
in which the role of hapten is played by public H-2 specifities and that of the
carrier determinant by either private H-2 specificities or structures closely linked
to them. Various models of steric arrangement of MHC determinants recognized
by receptors of effector T lymphocytes are discussed.
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